BRIEF-Sagimet Biosciences – Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30

2

Sept 30 (Reuters) – Sagimet Biosciences Inc.: * SAGIMET BIOSCIENCES – SUSPENDS AND TERMINATES ATM PROSPECTUS SUPPLEMENT FOR SERIES A COMMON STOCK EFFECTIVE SEPT 30 – SEC FILING Further company

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)